Cargando…

Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy

Dendritic cell (DC)‐based cancer immunotherapy has exhibited remarkable clinical prospects because DCs play a central role in initiating and regulating adaptive immune responses. However, the application of traditional DC‐mediated immunotherapy is limited due to insufficient antigen delivery, inadeq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Heng, Li, Qiang, Zhang, Yu, Ding, Meng, Teng, Zhaogang, Mou, Yongbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288267/ https://www.ncbi.nlm.nih.gov/pubmed/37088780 http://dx.doi.org/10.1002/advs.202301339

Ejemplares similares

Therapeutic Applications of Antimicrobial Silver-Based Biomaterials in Dentistry
por: Wang, Qiyu, et al.
Publicado: (2022)

Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy
por: Calmeiro, João, et al.
Publicado: (2019)

Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy
por: He, Ao, et al.
Publicado: (2023)

Engineered biomaterials for cancer immunotherapy
por: Cai, Lulu, et al.
Publicado: (2020)

Supramolecular Biomaterials for Cancer Immunotherapy
por: Liang, Huan, et al.
Publicado: (2023)

Advanced biomaterials for cancer immunotherapy
por: Yang, Fan, et al.
Publicado: (2020)

Radiotherapy combined with nano-biomaterials for cancer radio-immunotherapy
por: Dong, Qingrong, et al.
Publicado: (2023)

Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma
por: Yu, Chenhang, et al.
Publicado: (2022)

Biomaterials for enhanced immunotherapy
por: Cunningham, Nicholas, et al.
Publicado: (2022)

Emerging nanosonosensitizers augment sonodynamic-mediated antimicrobial therapies
por: Xu, Qinglin, et al.
Publicado: (2023)

The role of dendritic cells in the immunomodulation to implanted biomaterials
por: Wang, Siyuan, et al.
Publicado: (2022)

Emerging biomaterials for tumor immunotherapy
por: Xiao, Minna, et al.
Publicado: (2023)

Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy
por: Ruan, Shaobo, et al.
Publicado: (2022)

Improving the clinical impact of biomaterials in cancer immunotherapy
por: Gammon, Joshua M., et al.
Publicado: (2016)

Plasmacytoid Dendritic Cells and Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2022)

IFN-Alpha-Mediated Differentiation of Dendritic Cells for Cancer Immunotherapy: Advances and Perspectives
por: Lapenta, Caterina, et al.
Publicado: (2020)

Research progress on dendritic cell vaccines in cancer immunotherapy
por: Yu, Jifeng, et al.
Publicado: (2022)

Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
por: Nava, Sara, et al.
Publicado: (2021)

Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
por: Luo, Shumin, et al.
Publicado: (2023)

Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy
por: Wei, Qi, et al.
Publicado: (2022)

Electroactive Biomaterials for Facilitating Bone Defect Repair under Pathological Conditions
por: Heng, Boon Chin, et al.
Publicado: (2022)

Recent applications of immunomodulatory biomaterials for disease immunotherapy
por: Dai, Huaxing, et al.
Publicado: (2022)

Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy
por: Liu, Hongyu, et al.
Publicado: (2017)

Dendritic Cell-Based Immunotherapy for Prostate Cancer
por: Jähnisch, Hanka, et al.
Publicado: (2010)

Cancer Immunotherapy: Silencing Intracellular Negative Immune Regulators of Dendritic Cells
por: Liu, Yao-Hua, et al.
Publicado: (2019)

Dendritic Cell-Based Immunotherapies and their Potential use in Colorectal Cancer Immunotherapy
por: Aldahlawi, Alia M., et al.
Publicado: (2021)

Recent Progress in Dendritic Cell-Based Cancer Immunotherapy
por: Matsuo, Kazuhiko, et al.
Publicado: (2021)

Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
por: Calmeiro, João, et al.
Publicado: (2020)

Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go?
por: Li, Xuefeng, et al.
Publicado: (2022)

Dendritic cell immunotherapy: clinical outcomes
por: Apostolopoulos, Vasso, et al.
Publicado: (2014)

Implantable and Injectable Biomaterial Scaffolds for Cancer Immunotherapy
por: Li, Jie, et al.
Publicado: (2020)

Biofilm Microenvironment-Responsive Nanotheranostics for Dual-Mode Imaging and Hypoxia-Relief-Enhanced Photodynamic Therapy of Bacterial Infections
por: Xiu, Weijun, et al.
Publicado: (2020)

Stem cell therapies for periodontal tissue regeneration: a network meta-analysis of preclinical studies
por: Li, Qiang, et al.
Publicado: (2020)

Biomaterials promote in vivo generation and immunotherapy of CAR-T cells
por: Qin, Ya-Ting, et al.
Publicado: (2023)

Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells
por: Gessani, Sandra, et al.
Publicado: (2019)

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
por: Laureano, Raquel S, et al.
Publicado: (2022)

Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation
por: Sittig, Simone P., et al.
Publicado: (2015)

Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells
por: Dong, Heng, et al.
Publicado: (2018)

Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy
por: Hernández, Sabina Sánchez, et al.
Publicado: (2022)

Dendritic cell biology and its role in tumor immunotherapy
por: Wang, Yingying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_251qplt68ori5sgir0kas37gfe